ArticleCureus2025
A Case of Multiple Dural Arteriovenous Fistula-Like Findings Following Aneurysmal Subarachnoid Hemorrhage.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dural arteriovenous fistula (dAVF) is thought to arise from triggers like venous sinus thrombosis or trauma, though many aspects remain unclear. We report the case of a 48-year-old woman who developed multiple asymptomatic dAVF-like findings two weeks after coil embolization for subarachnoid hemorrhage (SAH). Initial angiography showed no dAVFs. Postoperative angiography showed cavernous sinus and middle meningeal artery dAVF-like findings without cortical venous reflux. Conservative management was chosen, and follow-up angiography at three months showed spontaneous resolution. The incidental emergence of multiple dAVF-like findings suggests that increased intracranial pressure due to SAH may have opened "direct physiological arteriovenous pathways", contributing to the development of dAVF. To the best of our knowledge, no previous reports have described a case presenting dAVF-like findings within a short period (two weeks) following an uneventful endovascular treatment. This case provides important insights into the existence and activation of "direct physiological arteriovenous pathways" and may contribute to a better understanding of the pathophysiology and mechanisms underlying dAVF development in human.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.